Literature DB >> 15163755

Role of an arbovirus nonstructural protein in cellular pathogenesis and virus release.

Randall J Owens1, Chang Limn, Polly Roy.   

Abstract

The insect-borne Bluetongue virus (BTV) is considered the prototypic Orbivirus, a member of the Reovirus family. One of the hallmarks of Orbivirus infection is the production of large numbers of intracellular tubular structures of unknown function. For BTV these structures are formed as the polymerization product of a single 64-kDa nonstructural protein, NS1, encoded by the viral double-stranded RNA genome segment 6. Although the NS1 protein is the most abundant viral protein synthesized in infected cells, its function has yet to be determined. One possibility is that NS1 tubules may be involved in the translocation of newly formed viral particles to the plasma membrane, and NS1-specific monoclonal antibodies have been shown to react with viral particles leaving infected cells. In the present study we generated a mammalian cell line that expresses a recombinant single-chain antibody fragment (scFv) derived from an NS1-specific monoclonal antibody (10B1) and analyzed the effect that this intracellular antibody has on BTV replication. Normally, BTV infection of mammalian cells in culture results in a severe cytopathic effect within 24 to 48 h postinfection manifested by cell rounding, apoptosis, and lytic release of virions into the culture medium. However, infection of scFv-expressing cells results in a marked reduction in the stability of NS1 and formation of NS1 tubules, a decrease in cytopathic effect, an increased release of infectious virus into the culture medium, and budding of virions from the plasma membrane. These results suggest that NS1 tubules play a direct role in the cellular pathogenesis and morphogenesis of BTV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163755      PMCID: PMC416502          DOI: 10.1128/JVI.78.12.6649-6656.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  How a rotavirus hijacks the human protein synthesis machinery.

Authors:  Gabriele Varani; Frédéric H-T Allain
Journal:  Nat Struct Biol       Date:  2002-03

2.  AN OVINE FETAL ENCEPHALOPATHY CAUSED BY BLUETONGUE VACCINE VIRUS.

Authors:  S YOUNG; D R CORDY
Journal:  J Neuropathol Exp Neurol       Date:  1964-10       Impact factor: 3.685

3.  NS1 protein of influenza A virus down-regulates apoptosis.

Authors:  O P Zhirnov; T E Konakova; T Wolff; H-D Klenk
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS.

Authors:  Diana L Noah; Karen Y Twu; Robert M Krug
Journal:  Virology       Date:  2003-03-15       Impact factor: 3.616

5.  Inhibition of protein synthesis by the nonstructural proteins NS4A and NS4B of hepatitis C virus.

Authors:  Ruth H Florese; Motoko Nagano-Fujii; Yasuhiro Iwanaga; Rachmat Hidajat; Hak Hotta
Journal:  Virus Res       Date:  2002-12       Impact factor: 3.303

6.  The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release.

Authors:  Andrew R Beaton; Javier Rodriguez; Y Krishnamohan Reddy; Polly Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

7.  Virus-derived tubular structure displaying foreign sequences on the surface elicit CD4+ Th cell and protective humoral responses.

Authors:  M K Ghosh; M V Borca; Polly Roy
Journal:  Virology       Date:  2002-10-25       Impact factor: 3.616

8.  Induction of HLA-A2-restricted CTL responses by a tubular structure carrying human melanoma epitopes.

Authors:  Mrinal K Ghosh; Cui-Ling Li; Catherine Fayolle; Gilles Dadaglio; Aileen Murphy; François A Lemonnier; Polly Roy; Claude Leclerc
Journal:  Vaccine       Date:  2002-06-07       Impact factor: 3.641

9.  Construction and characterization of an intracellular single-chain human antibody to hepatitis C virus non-structural 3 protein.

Authors:  Deborah E Sullivan; Mario U Mondelli; David T Curiel; Viktor Krasnykh; Gallina Mikheeva; Paul Gaglio; Cindy B Morris; Srikanta Dash; Michael A Gerber
Journal:  J Hepatol       Date:  2002-11       Impact factor: 25.083

10.  Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication.

Authors:  Menashe Elazar; Kwang Ho Cheong; Ping Liu; Harry B Greenberg; Charles M Rice; Jeffrey S Glenn
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more
  36 in total

1.  Type I interferon limits the capacity of bluetongue virus to infect hematopoietic precursors and dendritic cells in vitro and in vivo.

Authors:  Teresa Rodríguez-Calvo; José-Manuel Rojas; Verónica Martín; Noemí Sevilla
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

2.  Virus-induced autophagic degradation of STAT2 as a mechanism for interferon signaling blockade.

Authors:  Miguel Avia; José M Rojas; Lisa Miorin; Elena Pascual; Piet A Van Rijn; Verónica Martín; Adolfo García-Sastre; Noemí Sevilla
Journal:  EMBO Rep       Date:  2019-10-11       Impact factor: 8.807

3.  Novel Function of Bluetongue Virus NS3 Protein in Regulation of the MAPK/ERK Signaling Pathway.

Authors:  Damien Vitour; Grégory Caignard; Cindy Kundlacz; Marie Pourcelot; Aurore Fablet; Rayane Amaral Da Silva Moraes; Thibaut Léger; Bastien Morlet; Cyril Viarouge; Corinne Sailleau; Mathilde Turpaud; Axel Gorlier; Emmanuel Breard; Sylvie Lecollinet; Piet A van Rijn; Stephan Zientara
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

4.  A correlation between capsid protein VP2 and the plaque morphology of African horse sickness virus in cell culture.

Authors:  Mathilde L Schade-Weskott; Antoinette van Schalkwyk; J J O Koekemoer
Journal:  Virus Genes       Date:  2018-05-05       Impact factor: 2.332

5.  Drosophila melanogaster as a model organism for bluetongue virus replication and tropism.

Authors:  Andrew E Shaw; Eva Veronesi; Guillemette Maurin; Najate Ftaich; Francois Guiguen; Frazer Rixon; Maxime Ratinier; Peter Mertens; Simon Carpenter; Massimo Palmarini; Christophe Terzian; Frederick Arnaud
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

6.  Turnover Rate of NS3 Proteins Modulates Bluetongue Virus Replication Kinetics in a Host-Specific Manner.

Authors:  Najate Ftaich; Claire Ciancia; Cyril Viarouge; Gerald Barry; Maxime Ratinier; Piet A van Rijn; Emmanuel Breard; Damien Vitour; Stephan Zientara; Massimo Palmarini; Christophe Terzian; Frédérick Arnaud
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

7.  Epizootic hemorrhagic disease virus induces and benefits from cell stress, autophagy, and apoptosis.

Authors:  Ben Shai; Eran Schmukler; Roy Yaniv; Naomi Ziv; Galit Horn; Velizar Bumbarov; Hagai Yadin; Nechama I Smorodinsky; Eran Bacharach; Ronit Pinkas-Kramarski; Marcelo Ehrlich
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

Review 8.  The molecular biology of Bluetongue virus replication.

Authors:  Avnish Patel; Polly Roy
Journal:  Virus Res       Date:  2013-12-25       Impact factor: 3.303

9.  Bluetongue virus VP6 acts early in the replication cycle and can form the basis of chimeric virus formation.

Authors:  Eiko Matsuo; Polly Roy
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

10.  RNA interference targets arbovirus replication in Culicoides cells.

Authors:  Esther Schnettler; Maxime Ratinier; Mick Watson; Andrew E Shaw; Melanie McFarlane; Mariana Varela; Richard M Elliott; Massimo Palmarini; Alain Kohl
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.